A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta | MicrobiomeTrials
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-12-19Est. Completion: 2027-11
Enrollment target: 150 participants
Locations
Keck Medicine of USC, Los Angeles, California, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Medstar Washington Hospital Center, Washington D.C., District of Columbia, United States
UF Health Shands Hospital, Gainesville, Florida, United States
Tampa General Hospital, Tampa, Florida, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Barnes-Jewish Hospital, St Louis, Missouri, United States
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
UPMC Presbyterian, Pittsburgh, Pennsylvania, United States
Acension Seton Medical Center, Austin, Texas, United States
Baylor Scott & White The Heart Hospital - Plano, Plano, Texas, United States
Froedhert Hospital, Milwaukee, Wisconsin, United States
Other microbiome trials you might be interested in